- Tunisia readies for vote as incumbent Saied eyes victory
- High childcare costs in US weigh on women's employment
- US voters seek help with crushing childcare costs
- Taiwan shuts down for second day as Typhoon Krathon to land
- Supercharged storms: how climate change amplifies cyclones
- Biden official urges talks as US port strike enters second day
- Huge protests in Argentina over public university cuts
- Rally in oil prices loses steam on mixed day for global stocks
- South America treated to rare 'ring of fire' eclipse
- Biden official says port strike deal not as far as parties think
- Mexico's new president offers apology for 1968 student massacre
- Historic funding round values OpenAI at $157 billion
- Mixed US car sales in Q3 as industry hopes for post-election bounce
- Thunderstorms are a 'boiling pot' of gamma rays, scientists find
- Scientists unlock secret of 'Girl With Pearl Earring'
- Dolphins flash friendly grins when they're ready to play
- Facing backlash, EU moves to delay deforestation rules
- US private sector adds more jobs than expected in September: ADP
- Boys out of critical condition after Zurich stabbings
- Spain logs record summer tourism as inflow draws protests
- Hedi Slimane quits as Celine's artistic director
- Oil prices extend rally on Iran attack
- Spain welcomed record number of tourists this summer
- France says coming tax hikes on the wealthy to be 'temporary'
- Why are Thailand's roads so deadly?
- Oracle to invest $6.5 bn in Malaysian cloud services region
- Parkrun marks 20 years of a free weekly jog, run... or walk
- Oil extends rally after Iran attack, Hong Kong soars again
- Prostitutes, prospectors drive spread in DR Congo mpox capital
- Oil extends rally after Iran attack, Hong Kong resumes surge
- Extreme heat another form of death sentence in Texas jails
- Can music help plants grow? Study suggests sound boosts fungus
- Nike earnings drop, says turnaround will take time
- US dockworkers launch mass strike a month before election
- Iron Dome: Israel's key anti-missile shield
- Cranes stand still as US dockworkers fight for 'future'
- GM reports US sales dip, but says EVs grew
- Sheinbaum takes office as Mexico's first woman president
- Webb telescope detects carbon dioxide on Pluto's largest moon
- Stock markets slump, oil jumps on Middle East concerns
- French PM vows more taxes and spending cuts ahead of budget fight
- Germany inaugurates IBM's first European quantum data centre
- Stock markets diverge as eurozone inflation drops further
- France's richest man takes control of Paris Match magazine
- Anger meets tear gas as Nigeria hardship protests fizzle out
- US dockworkers launch mass strike month before election
- Evacuations from Lebanon: what we know
- Feathers fly at Chanel's Paris fashion return
- UAE oil giant ADNOC swoops on German chemicals firm Covestro
- Eurozone inflation falls under 2% for first time since 2021
RBGPF | -2.18% | 59.5 | $ | |
SCS | -2.56% | 12.87 | $ | |
CMSD | -0.04% | 24.93 | $ | |
CMSC | 0.04% | 24.78 | $ | |
AZN | 1.14% | 79.58 | $ | |
BTI | -1.33% | 35.97 | $ | |
RELX | -0.11% | 47.29 | $ | |
NGG | -1.85% | 68.78 | $ | |
GSK | -2.15% | 39.45 | $ | |
BP | 0.86% | 32.37 | $ | |
RIO | -0.48% | 70.82 | $ | |
BCE | -1.13% | 34.44 | $ | |
RYCEF | -0.43% | 6.9 | $ | |
JRI | -1.12% | 13.38 | $ | |
BCC | -1.33% | 139.53 | $ | |
VOD | -2.16% | 9.74 | $ |
US approves Covid vaccines for youngest kids
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
The United States thus became the first country to approve use of the so-called mRNA vaccines for children as young as six months.
The US Food and Drug Administration (FDA) had on Friday authorized their emergency use for young children -- who previously had to be at least five to receive the vaccine.
But the vaccines required further clearance from the US Centers for Disease Control and Prevention (CDC), the country's leading public health agency -- and they received that on Saturday.
"We know millions of parents and caregivers are eager to get their young children vaccinated, and with today's decision, they can," CDC Director Rochelle Walensky said in a statement Saturday.
Once the green light was received from the FDA, the US government began distributing millions of doses of the vaccine across the country.
Biden promised that parents could begin scheduling appointments as early as next week to have their young children vaccinated at hospitals, clinics, pharmacies and doctor's offices.
In a statement Saturday, he touted the vaccines as "safe (and) highly effective," and said that "for parents all over the country, this is a day of relief and celebration."
In coming weeks, with more and more doses shipped out, "every parent who wants a vaccine will be able to get one," he said.
The Moderna vaccine, administered in two doses a month apart, will be available to children aged six months to five years in reduced doses of 25 micrograms (half the amount given children aged six to 11, and a quarter the dose for those 12 and older).
The Pfizer-BioNTech vaccine is now authorized for children aged six months to four years, and will be given in doses of three micrograms per injection -- one-tenth the adult dosage.
The difference, however, is that children will receive three shots -- the first two three weeks apart, followed by a third eight weeks later.
So, children receiving it will not have full protection for the first few months.
Its side effects, however, have appeared less serious in drug trials than those of the Moderna vaccine.
About a quarter of young children receiving Moderna have developed fevers, particularly after the second dose -- but they generally lasted no more than a day.
About 20 million US children are now eligible, by age, for the new vaccines.
While children have generally proved less vulnerable to Covid-19, some 480 in the US in this age group have died of the virus.
So-called long Covid is also a concern, as is multisystem inflammatory syndrome, a rare but serious post-viral condition.
Pfizer has said it hopes to apply in early July to the European Medicines Agency for authorization to provide its vaccines to children in this youngest age group.
A.Agostinelli--CPN